منابع مشابه
How we treat Richter syndrome.
Richter syndrome (RS) is defined as the transformation of chronic lymphocytic leukemia (CLL) into an aggressive lymphoma, most commonly diffuse large B-cell lymphoma (DLBCL). RS occurs in approximately 2% to 10% of CLL patients during the course of their disease, with a transformation rate of 0.5% to 1% per year. A combination of germline genetic characteristics, clinical features (eg, advanced...
متن کاملHow we treat tumor lysis syndrome.
Tumor lysis syndrome (TLS) is an oncology emergency that occurs as a result of rapid tumor cell breakdown and the consequent release of massive amounts of intracellular contents, including potassium, phosphate, and uric acid, into the systemic circulation. These metabolic disturbances lead to life-threatening conditions and may cause sudden death if not treated. TLS commonly occurs following in...
متن کاملHow I treat How we diagnose the antiphospholipid syndrome
The antiphospholipid syndrome (APS) is an acquired thrombophilia, characterized by the occurrence of venous and arterial events. This article examines the laboratory and key clinical aspects of APS. Particular focus is given to anti–beta 2glycoprotein I ( 2GPI) antibodies in view of their recent inclusion in the APS classification criteria. The clinical utility of using the 2GPI enzyme-linked i...
متن کاملHow I Treat How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia
Differentiation syndrome (DS), originally described as retinoic acid syndrome, is a relatively common and serious complication that can occasionally be life-threatening in patients with acute promyelocytic leukemia (APL) undergoing induction therapy with all-trans retinoic acid (ATRA) and/or arsenic trioxide (ATO). The full-blown syndrome is characterized by unexplained fever, weight gain, peri...
متن کاملHow I Treat How we treat lower-risk myelodysplastic syndromes
Myelodysplastic syndromes (MDSs) are clonal stem cell disorders characterized by ineffective hematopoiesis leading to blood cytopenias, and by a high incidence of progression to acute myeloid leukemia (AML). The pathophysiology of MDS is a multistep process involving genetic changes detectable by conventional cytogenetic techniques or smaller anomalies detectable only by more sophisticated meth...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood
سال: 2014
ISSN: 0006-4971,1528-0020
DOI: 10.1182/blood-2013-11-516229